Save The Date: Roche Virtual Event – Key ophthalmology data presented at the Angiogenesis 2023 Meeting Freitag, 13. Januar 2023 - 10:44
| Investor Update |  |
We are pleased to invite investors and analysts to participate in our virtual event on Monday, 13 February 2023, highlighting Roche data presented at the virtual Angiogenesis, Exudation, and Degeneration 2023 Meeting, from 10th to 11th February.
16:30 – 18:00 CET / 15:30 – 17:00 GMT 10:30 – 12:00 pm EST / 7:30 – 9:00 am PST
An invitation with the detailed programme and registration link will follow soon.
Best regards,
| ||
Bruno Eschli
|
| Loren Kalm Head of Investor Relations, North America |
Roche Investor Relations |
|
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com
| Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
|
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
| Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
|
|
Investor Relations North America |
|
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
|
All rights reserved ©2022 F. Hoffmann-La Roche Ltd.
Group Communications, Grenzacherstrasse 124, CH-4070 Basel, Switzerland